Microarray Screening for Novel Preeclampsia Biomarker Candidates

Publisher： Karger

E-ISSN： 1421-9964|31|3|147-153

ISSN： 1015-3837

Source： Fetal Diagnosis and Therapy, Vol.31, Iss.3, 2012-03, pp. : 147-153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Competing Risks Model in Early Screening for Preeclampsia

By  

Fetal Diagnosis and Therapy, Vol. 32, Iss. 3, 2012-07 ,pp. : 171-178

Karger

Access to resources Recommend Favorite

Insulin Resistance Is Associated with Gestational Hypertension and Not with Preeclampsia: A Population-Based Screening Study

By  

Gynecologic and Obstetric Investigation, Vol. 71, Iss. 4, 2010-12 ,pp. : 256-261

Karger

Access to resources Recommend Favorite

Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers

By  

Fetal Diagnosis and Therapy, Vol. 33, Iss. 1, 2012-08 ,pp. : 8-15

Karger

Access to resources Recommend Favorite

Combined Screening for Preeclampsia and Small for Gestational Age at 11–13 Weeks

By  

Fetal Diagnosis and Therapy, Vol. 33, Iss. 1, 2012-09 ,pp. : 16-27

Karger

Access to resources Recommend Favorite

Circulating mRNA for the PLAC1 Gene as a Second Trimester Marker (14-18 Weeks' Gestation) in the Screening for Late Preeclampsia

By  

Fetal Diagnosis and Therapy, Vol. 36, Iss. 3, 2014-08 ,pp. : 196-201

Karger

Access to resources Recommend Favorite